SOAPware Learning CenterClinical Quality Measures User Guide (for 2011) Additional Measures (Choose 3 Additional Measures) NQF 0385 (Additional): Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients

NQF 0385 (Additional): Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients

Measure: NQF 0385 (Additional Measurement)

Measure Title:   Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients  

Measure Description:  Percentage of patients aged 18 years and older with Stage IIIA through IIIC colon cancer whom are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period.

Quality Measure Documentation Workflow

In Order for the Clinical Quality Measure report to generate, the following must be documented in the relevant patient's chart:

1. The patient must be at least 18 years or older at the start of the reporting period and have at least one face-to-face encounter with the provider during the reporting period.

2. Documentation that the patient has Stage IIIA through IIIC colon cancer.  Inserting the shortcut code "PQRIcol" in the encounter Plan or Summary Interventions field will allow the user to select from a group of specific SMARText codes that can be used to document for this measure.  The encounter Plan or Summary Interventions field must include the following code to document Stage IIIA through IIIC colon cancer: 3388F. *Note: 3382F, 3384F, 3386F and 3390F will not increase the denominator.

3.  Documentation that the patient was referred for adjuvant chemotherapy,  prescribed adjuvant chemotherapy , or has previously received adjuvant chemo therapy within the 12 month reporting period.  Inserting the shortcut code "PQRIcol" in the encounter Plan or Summary Interventions field will allow the user to select from a group of specfic SMARText codes that can be used to document for this measure.  The encounter Plan or Summary Interventions field must include the following code to document that adjuvant chemotherapy has been suggested: 4180F.  *Note: 4180F-1P, 4180F-2P, 4180F-3P and 4180F-8P will not increase the numerator.

*If the above is documented appropriately, this should increase the numerator and denominator for this measure to indicate that the patient is 18 years or older with stage IIIA through IIIC colon cancer during the 12 month reporting period, have been referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy or has previously received adjuvant chemotherapy within the 12 month reporting period.

 

Measure Calculation Details

Numerator Calculation:

The numerator for this measure is calculated based on the following:

1.  The number of patients in the denominator for whom adjuvant chemotherapy has been suggested and document by using SMARText code 4180F in the encounter Plan or Summary Interventions field.  The pick list "PQRIcol" can be used to document this.

*Note: 4180F-1P, 4180F-2P, 4180F-3P and 4180F-8P will not increase the numerator.

Denominator Calculation:

The denominator for this measure is calculated based on the following:

1.  The number of patients that were at least 18 at the start of the reporting period and have at least one face-to-face encounter with the provider during the reporting period;

2.  And have documentation of Stage III Colon Cancer by using SMARText code 3388F in the encounter Plan Field or Summary Interventions field.  The pick list "PQRIcol" can be used to document this.

*Note: 3382F, 3384F, 3386F and 3390F will not increase the denominator.

Report Clinical Quality Measures to CMS/Status

All of the items listed in the above steps need to be documented as structured data (as detailed above) in order to allow the user to capture the numerator, denominator and percentage for this quality measure.

For information on how to export the numerator, denominator and percentage for each Clinical Quality Measure, click here.

For more information on reporting clinical quality measures, click here.